The role of patient-specific variables in protein corona formation and therapeutic efficacy in nanomedicine
{{output}}
Despite their potential, the adoption of nanotechnology in therapeutics remains limited, with only around eighty nanomedicines approved in the past 30 years. This disparity is partly due to the "one-size-fits-all" approach in medical design, which often overlo... ...
